Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sotera Health Company (SHC:NASDAQ), powered by AI.
Sotera Health Company is currently trading at $16.19. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sotera Health Company on Alpha Lenz.
Sotera Health Company's P/E ratio is 59.0.
“Sotera Health Company trades at a P/E of 59.0 (premium valuation) with strong ROE of 15.4%. Operating margin of 31.1% indicates strong profitability.”
Ask for details →Sotera Health Company is a leading provider of mission-critical health and sterilization services. It plays a vital role in ensuring safety and compliance across medical device, pharmaceutical, food, and other industries that require stringent sterilization and laboratory testing services. The company operates under three key business units: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides end-to-end sterilization solutions using innovative technologies to eliminate pathogens from medical and other consumable products. Nordion is instrumental in supplying Cobalt-60 that facilitates the radiation sterilization process, essential for medical devices, pharmaceuticals, and food safety industries. Nelson Labs delivers comprehensive testing and consultancy services, supporting organizations in gaining and maintaining regulatory approvals. Sotera Health's integrated solutions are crucial for maintaining public health standards and meeting regulatory compliance, making it an indispensable entity in the global health landscape. As an established operator with a broad international presence, Sotera Health Company underscores the importance of safety and reliability in its service offerings, significantly impacting industries reliant on rigorous safety standards.
“Sotera Health Company trades at a P/E of 59.0 (premium valuation) with strong ROE of 15.4%. Operating margin of 31.1% indicates strong profitability.”
Ask for details →Sotera Health Company (ticker: SHC) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 3,000 employees. Market cap is $4.6B.
The current price is $16.19 with a P/E ratio of 58.98x and P/B of 7.59x.
ROE is 15.42% and operating margin is 31.11%. Annual revenue is $1.2B.